Agile Therapeutics Inc (AGRX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Results
download Want to compare other data? Select Fields| Symbol | AGRX | TEVA | BBIO | RDY | SUPN |
| Company | Agile Therapeutics Inc | Teva Pharmaceutical Industries ADR | Bridgebio Pharma Inc | Dr. Reddy's Laboratories Ltd ADR | Supernus Pharm |
| Price Information | |||||
| Exchange | OTC US | NYSE | NASDAQ | NYSE | NASDAQ |
| Open | 1.5100 | 33.87 | 75.03 | 14.16 | 47.49 |
| High | 1.5150 | 34.92 | 77.26 | 14.49 | 48.11 |
| Low | 1.5100 | 33.59 | 74.49 | 14.16 | 46.97 |
| Latest | 1.5100 | 34.64 | 77.19 | 14.38 | 48.05 |
| Change | unch | +1.20 | +2.67 | +0.39 | +0.64 |
| % Change | unch | +3.59% | +3.58% | +2.79% | +1.35% |
| Volume | 120,900 | 4,815,400 | 3,179,400 | 2,176,300 | 969,000 |
| 20-Day Average Volume | 65,545 | 5,877,600 | 3,874,195 | 2,540,320 | 832,865 |
| Previous Close | 1.5100 | 33.44 | 74.52 | 13.99 | 47.41 |
| Industry | Medical - Generic Drugs | Medical - Generic Drugs | Medical - Generic Drugs | Medical - Generic Drugs | Medical - Generic Drugs |
| Has Options | No | Yes | Yes | Yes | Yes |
| Technicals | |||||
| 20-Day Moving Average | 1.4681 | 33.57 | 69.25 | 13.87 | 45.22 |
| 20-Day Raw Stochastic | 87.50% | 86.29% | 99.42% | 50.19% | 98.94% |
| 20-Day Relative Strength | 81.96 | 54.31 | 66.25 | 55.96 | 55.83 |
| Weighted Alpha | -73.36 | +92.41 | +65.81 | -1.49 | +34.02 |
| Today's Opinion | 88% Buy | 72% Buy | 56% Buy | 40% Buy | 48% Sell |
| Previous Opinion | 88% Buy | 40% Buy | 40% Buy | 24% Buy | 56% Sell |
| Last Month's Opinion | 56% Buy | 80% Buy | 56% Sell | 100% Sell | 72% Sell |
| Performance | |||||
| 5-Days | |||||
| %Chg | +3.42% since 08/19/24 | +3.03% since 06/25/26 | +10.76% since 06/25/26 | -5.70% since 06/25/26 | +7.37% since 06/25/26 |
| Low | 1.4400 on 08/22/24 | 32.96 on 06/26/26 | 68.82 on 06/26/26 | 13.95 on 07/01/26 | 44.75 on 06/26/26 |
| High | 1.5200 on 08/22/24 | 34.92 on 07/02/26 | 77.26 on 07/02/26 | 15.67 on 06/26/26 | 48.11 on 07/02/26 |
| 1-Month | |||||
| %Chg | +4.14% since 07/26/24 | +4.72% since 06/02/26 | +20.84% since 06/02/26 | +10.36% since 06/02/26 | +9.03% since 06/02/26 |
| Low | 1.4300 on 07/29/24 | 30.80 on 06/18/26 | 62.71 on 06/03/26 | 12.95 on 06/03/26 | 42.45 on 06/16/26 |
| High | 1.5200 on 08/22/24 | 35.25 on 06/15/26 | 77.26 on 07/02/26 | 15.67 on 06/26/26 | 48.11 on 07/02/26 |
| 3-Month | |||||
| %Chg | +302.77% since 05/24/24 | +15.16% since 04/02/26 | +5.52% since 04/02/26 | +7.96% since 04/02/26 | -4.81% since 04/02/26 |
| Low | 0.3100 on 06/20/24 | 27.93 on 04/06/26 | 62.50 on 06/02/26 | 12.19 on 05/12/26 | 42.45 on 06/16/26 |
| High | 1.5200 on 08/22/24 | 36.99 on 05/07/26 | 84.75 on 04/28/26 | 15.67 on 06/26/26 | 52.96 on 05/06/26 |
| 6-Month | |||||
| %Chg | +86.83% since 02/26/24 | +11.92% since 01/02/26 | -1.34% since 01/02/26 | +3.75% since 01/02/26 | -2.87% since 01/02/26 |
| Low | 0.2000 on 03/26/24 | 27.93 on 04/06/26 | 62.50 on 06/02/26 | 12.19 on 05/12/26 | 42.45 on 06/16/26 |
| High | 1.5200 on 08/22/24 | 37.35 on 02/03/26 | 84.94 on 02/12/26 | 15.67 on 06/26/26 | 59.68 on 02/25/26 |
| Key Statistics | |||||
| Market Capitalization, $K | 10,353 | 39,829,520 | 15,118,510 | 12,002,410 | 2,788,822 |
| Shares Outstanding, K | 6,856 | 1,149,813 | 195,861 | 834,660 | 58,040 |
| Annual Sales | 19,590,000 | 17,258,000,000 | 502,080,000 | 3,580,000,000 | 718,950,000 |
| Annual Net Income | -14,470,000 | 1,411,000,000 | -724,930,000 | 456,000,000 | -38,550,000 |
| Last Quarter Sales | 5,580,000 | 3,982,000,000 | 194,520,000 | 593,010,000 | 207,710,000 |
| Last Quarter Net Income | -11,870,000 | 369,000,000 | -164,040,000 | -10,780,000 | -2,290,000 |
| 60-Month Beta | 1.58 | 0.86 | 0.95 | 0.25 | 0.54 |
| Per-Share Information | |||||
| Most Recent Earnings | -0.68 on 08/12/24 | 0.53 on 04/29/26 | -0.84 on 05/07/26 | 0.06 on 05/12/26 | 0.59 on 05/05/26 |
| Earnings Date | 11/14/24 | 07/29/26 | 08/04/26 | 07/22/26 | 08/04/26 |
| Most Recent Dividend | N/A | 0.072 on 11/27/17 | N/A | 0.071 on 07/25/25 | N/A |
| Next Ex-Dividends Date | N/A | 11/27/17 | N/A | 07/24/26 | N/A |
| Ratios | |||||
| Price/Earnings ttm | 0.00 | 11.86 | 0.00 | 22.93 | 19.43 |